Alliance for Pandemic Preparedness

January 21, 2021

Clinical and Laboratory Features of Hypercoagulability in COVID-19 and Other Respiratory Viral Infections amongst Predominantly Younger Adults with Few Comorbidities

Category:

Topic:

Keywords (Tags):

A retrospective cohort study among hospitalized COVID-19 patients (n=181) and patients with other respiratory viral infections (n=165) found similarly low rates of arterial or venous thrombotic events. However, clot waveform analysis parameters were significantly higher among severe than mild COVID-19 patients, suggesting increased risk for hypercoagulability. Patients in the ICU routinely received the thrombosis prevention measures of enoxaparin injections and pneumatic calf pumps, while preventive measures were not standardized among patients admitted to hospital ward units.

Tan et al. (Jan 19, 2021). Clinical and Laboratory Features of Hypercoagulability in COVID-19 and Other Respiratory Viral Infections amongst Predominantly Younger Adults with Few Comorbidities. Scientific Reports. https://doi.org/10.1038/s41598-021-81166-y